WR-2721: enhanced chemoprotection by increasing cyclophosphamide activation with phenobarbitol.
D004999:Amifostine / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001711:Biotransformation / Q000187:drug effects; D003520:Cyclophosphamide / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000633:toxicity; D005260:Female; D007700:Kinetics; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D009946:Organothiophosphorus Compounds; D003520:Cyclophosphamide; D004999:Amifostine; D010634:Phenobarbital